[1] Fan F, Jin L, Yang L. pH-sensitive nanoparticles composed solely of membrane-disruptive macromolecules for treating pancreatic cancer[J]. ACS Appl Mater Interfaces, 2021,13(11):12824-12835.DOI: 10.1021/acsami.0c16576.
[2] Tian X, Traub B, Shi J,et al. c-Jun N-terminal kinase 2 suppresses pancreatic cancer growth and invasion and is opposed by c-Jun N-terminal kinase 1[J]. Cancer Gene Ther, 2022,29(1):73-86.DOI: 10.1038/s41417-020- 00290-5.
[3] Kim JH, Lee SC, Oh SY,et al. Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study[J]. Cancer Commun (Lond), 2018,38(1):32.DOI: 10.1186/s40880-018-0304-1.
[4] Li Y, Yang N, Zhou X,et al. LncRNA and mRNA interaction study based on transcriptome profiles reveals potential core genes in the pathogenesis of human thoracic aortic dissection[J]. Mol Med Rep, 2018,18(3):3167-3176.DOI: 10.3892/mmr.2018.9308.
[5] Jiang X, Wang L, Xie S,et al. Long noncoding RNA MEG3 blocks telomerase activity in human liver cancer stem cells epigenetically[J]. Stem Cell Res Ther, 2020,11(1):518.DOI: 10.1186/s13287-020-02036-4.
[6] 沈雅婷.非诺贝特上调LncRNA MEG3激活p53抑制胰腺癌细胞的试验研究[D]. 苏州:苏州大学, 2018.
[7] Notas G, Panagiotopoulos A, Vamvoukaki R,et al. ERα36-GPER1 collaboration inhibits TLR4/NFκB-induced pro-inflammatory activity in breast cancer cells[J]. Int J Mol Sci, 2021,22(14):7603.DOI: 10.3390/ijms22147603.
[8] Li Z, Gao H, Liu Y,et al. Genetic variants in the regulation region of TLR4 reduce the gastric cancer susceptibility[J]. Gene, 2021,767:145181.DOI: 10.1016/j.gene.2020. 145181.
[9] 刘心悦,巫燕芬,马子骞,等. 胰腺癌患者临床特征及预后分析[J]. 河北医药,2020,42(11):1615-1619. DOI:10.3969/j.issn.1002-7386.2020.11.003.
[10] Reiss KA, Vonderheide RH. Alternatives to perpetual chemotherapy for metastatic pancreatic cancer[J]. Clin Cancer Res, 2021,27(13):3540-3542.DOI: 10.1158/1078-0432.CCR-21-0612.
[11] Li H, Wang P, Liu J,et al. Hypermethylation of lncRNA MEG3 impairs chemosensitivity of breast cancer cells[J]. J Clin Lab Anal, 2020 ,34(9):e23369.DOI: 10.1002/jcla.23369.
[12] Yan H, Luo B, Wu X,et al. Cisplatin induces pyroptosis via activation of MEG3/NLRP3/caspase-1/GSDMD pathway in triple-negative breast cancer[J]. Int J Biol Sci, 2021,17(10):2606-2621.DOI: 10.7150/ijbs.60292.
[13] Gao L, Shao T, Zheng W,et al. Curcumin suppresses tumor growth of gemcitabine-resistant non-small cell lung cancer by regulating lncRNA-MEG3 and PTEN signaling[J]. Clin Transl Oncol, 2021,23(7):1386-1393.DOI: 10.1007/s12094-020-02531-3.
[14] Yang Z, Wang Z, Duan Y. LncRNA MEG3 inhibits non-small cell lung cancer via interaction with DKC1 protein[J]. Oncol Lett, 2020 ,20(3):2183-2190.DOI: 10.3892/ol.2020.11770.
[15] 陈晓雷,杨秀丽,周天竹,等. 雷公藤红素上调lncRNA MEG3表达抑制肝癌细胞增殖及促进细胞凋亡[J]. 现代肿瘤医学,2019,27(5):739-742. DOI:10.3969/j.issn. 1672-4992.2019.05.006.
[16] Zhang Y, Liu J, Lv Y,et al. LncRNA meg3 suppresses hepatocellular carcinoma in vitro and vivo studies[J]. Am J Transl Res, 2019,11(7):4089-4099.
[17] Messaritakis I, Stogiannitsi M, Koulouridi A,et al. Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer[J]. PLoS One, 2018,13(6):e0197327. DOI: 10.1371/journal.pone.0197327.
[18] Deveci Ozkan A, Kaleli S, Onen HI,et al. Anti-inflammatory effects of nobiletin on TLR4/TRIF/IRF3 and TLR9/IRF7 signaling pathways in prostate cancer cells[J]. Immunopharmacol Immunotoxicol, 2020,42(2):93-100.DOI: 10.1080/08923973.2020.1725040.
[19] Zhang L, Shi H, Chen H,et al. Dedifferentiation process driven by radiotherapy-induced HMGB1/TLR2/YAP/HIF-1α signaling enhances pancreatic cancer stemness[J]. Cell Death Dis, 2019,10(10):724.DOI: 10.1038/s41419-019-1956-8.
[20] 孙运良,马建霞,满晓华,等. p38 MAPK信号通路在TLR4促进胰腺癌血管生成中的作用[J]. 重庆医学,2017,46(2):161-164. DOI:10.3969/j.issn.1671-8348.2017.02.005.
[21] Youn SE, Jiang F, Won HY,et al. PAUF induces migration of human pancreatic cancer cells exclusively via the TLR4/MyD88/NF-κB signaling pathway[J]. Int J Mol Sci, 2022,23(19):11414. DOI: 10.3390/ijms231911414.
[22] Yoon JH, Shin JW, Pham TH,et al. Methyl lucidone induces apoptosis and G2/M phase arrest via the PI3K/Akt/NF-κB pathway in ovarian cancer cells[J]. Pharm Biol, 2020,58(1):51-59.DOI: 10.1080/13880209.2019. 1701044.
[23] 孙联康,都大伟,钱伟崐,等. 趋化因子CXCL11激活NF-κB信号通路促进胰腺癌的侵袭转移及上皮间质转换[J]. 西安交通大学学报(医学版),2019,40(4):501-505. DOI:10.7652/jdyxb201904002.
[24] Suhail M, Tarique M, Muhammad N,et al. A critical transcription factor NF-κB as a cancer therapeutic target and its inhibitors as cancer treatment options[J]. Curr Med Chem, 2021,28(21):4117-4132.DOI: 10.2174/0929867327666201111142307.
[25] 陈鹏,崔锐,梁鸿飞,等. miR-195靶向TLR4并阻断NF-κB通路抑制肝癌细胞HepG2增殖和转移[J]. 中国肿瘤生物治疗杂志,2019,26(5):550-556. DOI:10.3872/j.issn. 1007-385x.2019.05.011.
[26] Tao XW, Zeng LK, Wang HZ,et al. LncRNA MEG3 ameliorates respiratory syncytial virus infection by suppressing TLR4 signaling[J]. Mol Med Rep, 2018 ,17(3):4138-4144. DOI: 10.3892/mmr.2017.8303.
|